Increased neutrophil apoptosis in chronically SIV-infected macaques by Elbim, Carole et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Retrovirology
Open Access Short report
Increased neutrophil apoptosis in chronically SIV-infected 
macaques
Carole Elbim1, Valérie Monceaux2, Stéphanie François3, Bruno Hurtrel2, 
Marie-Anne Gougerot-Pocidalo3 and Jérome Estaquier*2,4,5
Address: 1Centre de Recherche des Cordeliers, Université Pierre et Marie Curie – Paris 6, UMR S 872, Paris, F-75006 France; Université Paris 
Descartes, UMR S 872, Paris, F-75006, France, 2Institut Pasteur, Unité de Physiopathologie des Infections Lentivirales, Paris, F-75015, France, 3AP-
HP, Centre Hospitalier Universitaire Xavier Bichat, Service d'Immunologie et d'Hématologie, Paris, F-75018, France, 4INSERM, U841, Faculté de 
Médecine de Créteil,  Créteil, F-94010, France and 5AP-HP, Hôpital Henri Mondor, Créteil, F-94010, France
Email: Carole Elbim - carole.elbim@crc.jussieu.fr; Valérie Monceaux - valerie.monceaux@pasteur.fr; Stéphanie François - francois@inserm.fr; 
Bruno Hurtrel - bruno.hurtrel@pasteur.fr; Marie-Anne Gougerot-Pocidalo - marianne.pocidalo@bch.aphp.fr; 
Jérome Estaquier* - estaquier@yahoo.fr
* Corresponding author    
Abstract
Polymorphonuclear neutrophils (PMN) from chronically HIV-infected individuals have been
reported to be more prone to die. However, although non-human primates models have been
extensively used for improving our knowledge on T cell immunity, the impact of SIV-infection on
PMN, in relationships with disease severity, has never been assessed. In our study, we demonstrate
that PMN from Rhesus macaques (RMs) of Chinese origin chronically infected with the virulent
strain SIVmac251 display increased susceptibility to undergo apoptosis as compared to PMN from
RMs infected with the non-pathogenic SIVΔnef strain. PMN apoptosis was significantly increased in
RMs progressing faster to AIDS as compared to non-progressors RMs. Furthermore, the
percentage of apoptotic cells correlated with PMN activation state reflected by increased CD11b
expression and reactive oxygen species production. Interestingly, whereas inflammatory cytokines
IL-8 and IL-1β prevent in vitro PMN death, the levels of those cytokines were low in RMs
progressing towards AIDS. Altogether, increased PMN death during SIV infection is a new
pathogenic effect associated with AIDS progression, adding to the long list of markers associated
with disruption of defense against infection.
Findings
Polymorphonuclear neutrophils (PMN) are key compo-
nents of the first line of defense against pathogens [1].
PMN are terminally differentiated cells with a short life
span; they die spontaneously by apoptosis and are then
recognized and phagocytosed by macrophages [2]. Short-
ened PMN survival due to apoptosis may explain suscep-
tibility to severe and recurrent infections in some
pathological situations [3,4].
It has been reported that PMN functions are impaired in
the latter stages of HIV infection[5]; increased PMN apop-
tosis has also been observed in HIV-infected patients hav-
ing less than 200 CD4+ cells/mm3 [6-11]; however, the
introduction of HAART has reduced spontaneous PMN
apoptosis. Several lines of evidence suggest a key role of
PMN, at least through defensin expression, in controlling
viruses other than HIV or SIV [12-14]. In addition, human
neutrophil α-defensins 1–4 have been reported to inhibit
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HIV-1 replication in vitro [15-17], and activated neu-
trophils have been demonstrated to exert cytotoxic activity
against HIV-infected cells[18].
The use of non-human primate models, particularly SIV-
infected Rhesus macaques (RMs), has allowed the
detailed and sequential investigation of the events of SIV
infection in terms of virus dynamics, immune response,
and changes in the pool of CD4+ cells [19]. Once the set-
point phase is reached, the level of viral load predicts the
rate of progression to AIDS [20-22]. Thus, SIVmac infec-
tion of RMs has proved to be an invaluable animal model
for studies of AIDS pathogenesis, therapeutics, and vac-
cines. In particular, we and others have demonstrated that
RMs of Chinese origin is a particularly relevant model to
study human diseases [23-28]. Paradoxically, no studies
have investigated, in SIV-infected RMs, possible PMN dys-
regulation, especially the propensity of PMNs to die, in
relationships with disease severity.
Rhesus macaques (Macaca mulatta, RMs), of Chinese ori-
gin background, were confirmed, prior to infection, as
seronegative for STLV-1 (Simian T Leukemia Virus type-
1), SRV-1 (type D retrovirus), herpes-B viruses, and SIV-
mac. All animals were housed in compliance with French
regulations for animal care and usage http://www.pas
teur.fr/recherche/unites/animalerie/fichiers/
Decret200486.pdf, and were inoculated intravenously
with either pathogenic SIVmac251 strain [ten 50% animal
infectious doses (AID)] or the live attenuated
SIVmac251Δnef strain [two hundred 50% AID].
All the animals were challenged with the same batch of
virus, titrated in vivo in rhesus macaques, and were fol-
lowed post-infection and studied 8 months later. RNA
was extracted from plasma of SIV-infected monkeys, using
the TRI REAGENT BD Kit (Molecular Research Center Inc.,
Cincinnati, Ohio). Real-time quantitative reverse tran-
scriptase-polymerase chain reaction (RT-PCR) was used to
determine viral loads as previously described [22]. Among
SIV+ macaques, slow progressors (n = 6) and moderate
progressors (n = 5) were defined according to plasma viral
load (<103  copies/ml and 103–105  copies/ml, respec-
tively), that predicts further disease progression in RMs of
Chinese origin [20,21]. In contrast, in SIVΔnef-infected
monkeys, plasma viral load was always lower than 1.5 ×
102 copies/ml. Moreover, as shown in Table 1, CD4+ T cell
counts were significantly decreased in moderate progres-
sors as compared to SIV+ slow progressors, SIVΔnef  or
healthy (SIV-) macaques consistent with previous reports
[20,21].
To quantify PMN apoptosis, samples were analyzed
directly on the whole blood cooled to 4°C to avoid non-
specific activation due to isolation procedure [29,30].
PMN apoptosis was measured after 4 hours of incubation
in 24-well tissue culture-plates at 37°C with 5% CO2.
Apoptosis was quantified by allophycocyanin (APC)-con-
jugated annexin V and 7-amino-actinomycin D (7-AAD)
staining as previously described [29,30]. Whole blood
samples (100 μl) were washed twice in PBS, incubated
with FITC-anti-CD14 and PE-anti-CD11b monoclonal
antibodies (mAbs) for 15 minutes, and then incubated
with APC-annexin V for 15 minutes. After dilution in PBS
(500 μl) the samples were incubated with 7-AAD at room
temperature for 15 minutes and analyzed immediately by
flow cytometry. PMN were identified as CD11b+CD14low
cells (Figure 1A and 1B).
After 4 hours of incubation at 37°C, PMN apoptosis was
significantly increased in SIV+ macaques relative to SIVΔ-
nef and healthy controls (Figure 1D). The fact that SIVΔnef
macaques showed reduced susceptibility to apoptosis as
compared to SIV+ animals is in keeping with a previous
report that the apathogenic strain is associated with
milder immune dysfunction and has a lower plasma viral
Table 1: Characteristics of the study population a
SIV- SIVΔnef SIV+ slow progressors SIV+ moderate progressors
(n = 6) (n = 4) (n = 6) (n = 5)
PMN count b 1840 ± 259 1693 ± 325 1956 ± 252 1685 ± 245
Lymphocyte count b 3104 ± 212 2970 ± 451 3317 ± 608 2354 ± 230
CD4+ count b 1127 ± 232 1086 ± 320 848 ± 149 317 ± 79 d, e
CD8+ count b 651 ± 161 778 ± 184 1077 ± 277 1050 ± 232
Viral load c 0 1.22 ± 0.42 38 ± 19 d, e 1706 ± 699 d, e, f
a Monkeys were infected intravenously with 10 AID50 of the non-pathogenic nef-deleted SIVmac251 isolate (SIVΔnef) or the pathogenic strain 
SIVmac251 (SIV+) and were studied 8 months later.
Values are means ± SEM.
b PMN, lymphocytes, CD4+ and CD8+ counts are expressed per microliter.
c Viral load is expressed as 102 copies per milliliter.
d Significantly different from healthy controls (SIV-) (p < 0.05).
e Significantly different from SIVΔnef (p < 0.05).
f Significantly different from SIV+ slow progressors (p < 0.05).Retrovirology 2009, 6:29 http://www.retrovirology.com/content/6/1/29
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load [31]. Moreover, PMN apoptosis was significantly
increased in moderate progressors as compared to slow
progressors (percentage of annexin V+ cells: 33.0 ± 5.1 and
15.7 ± 1.5, in moderate and slow progressors respec-
tively). In addition, PMN apoptosis in individual SIV+
macaques correlated negatively with the corresponding
CD4+ T cell counts and positively with plasma viral load
(ρ = -0.59, p = 0.05 and ρ = 0.91, p = 0.0003, respectively)
(correlation was identified by means of the Spearman
rank correlation coefficient ρ). These results suggest that
the rate of PMN apoptosisis directly related to the speed of
disease progression. In accordance with the general view
that many cell types undergo death in a caspase-inde-
pendent manner [32,33], preincubation of whole blood
samples with the broad caspase inhibitor CBz-Val-Ala-DL-
Asp(Ome)-fluoromethylketone (z-VAD-fmk) (10 μM) for
15 minutes did not prevent PMN death in SIV+ macaques
(data not shown), whereas the same compound pre-
vented Fas-mediated apoptosis of CD8+ T cells in agree-
ment with previous reports [30,32,34]. Altogether, these
results suggest that PMN are abnormally primed to
undergo death through a caspase-independent pathway in
SIV-infected macaques progressing more rapidly to AIDS.
Whereas we found an increased PMN propensity to die,
this was not reflected by an apparent decline of PMN
counts (Table 1). This result contrasts with our recent data
observed during the acute phase of SIV infection in Chi-
nese RM demonstrating that PMN death is associated with
neutropenia early after infection [30]. Increased emigra-
tion from the bone marrow of mature PMN could be an
explanation compensating for the absence of apparent
depletion chronically infected macaques. Therefore, we
decided to analyze the basal activation status of PMN in
the periphery, by measuring CD11b expression and ROS
production. Superoxide anion O2
- production was meas-
ured with a flow cytometric assay derived from the
hydroethidine (HE) oxidation technique [29,30].
Both CD11b expression (Figure 2A) and ROS production
(Figure 2B) of resting PMN (maintained at 4°C) were sig-
nificantly increased in both slow and moderate progres-
sors relative to healthy and SIVΔnef controls. Furthermore,
PMN from moderate progressors exhibited increased
CD11b expression and ROS production as compared to
slow progressors. Interestingly, the percentage of apop-
totic cells correlated with basal PMN activation status (ρ =
0.69, p = 0.01 and ρ = 0.71, p = 0.01, for CD11b expres-
sion and ROS production, respectively). The conse-
quences of PMN activation generating general oxidative
stress molecules might include an increased PMN suscep-
tibility to apoptotic death during the chronic phase of
infection [35]. In addition, these results support the idea
that increased granulopoiesis in bone marrow leads to a
compensatory release of mature PMN. Interestingly, PMN
activation has been reported in the bone marrow of
chronically SIV-infected macaques [36], contrasting with
a defect in bone marrow lymphopoiesis [37,38]. Infact,
reciprocal dynamics of the bone marrow lymphocyte and
neutrophil populations lead to cellular competition
within a developmental niche. In particular, blocking
PMN apoptosis during chronic infection of rhesus macaques  with the pathogenic SIVmac251 strain Figure 1
PMN apoptosis during chronic infection of rhesus 
macaques with the pathogenic SIVmac251 strain. 
Panels A, B, and C show the gating strategy to quantify 
apoptosis. A) Dot plot showing anti-CD11b-PE staining 
against the side-scatter parameter. A first gate (R1) was 
drawn around CD11b+ cells. B. Dot plot showing anti-
CD11b-PE and anti-CD14-FITC staining, gated on R1. A sec-
ond gate (R2) was drawn on CD14low cells in order to elimi-
nate monocytes (CD14high cells) from the analysis. C) The 
combination of annexin V-APC and 7-AAD staining distin-
guished early apoptotic cells (annexin V+, 7-AAD-) and late 
apoptotic cells (annexin V+, 7-AAD+) in an SIV- macaque and 
in an SIV+ macaque moderate progressor (SIV+ MP) (day 240) 
after incubating whole blood at 37°C for 4 hours (T4h). 
Panel D. Eleven SIV+ (six slow progressors, SIV+ SP and five 
moderate progressors, SIV+ MP) and four SIVΔnef macaques 
were studied after 8 months of infection. Apoptosis was 
studied after incubating whole blood at 37°C for 4 hours 
(T4h). Results are expressed as percentage of annexin V+/7-
AAD- cells (early apoptotic cells). Data are reported as 
means ± SEM. Comparisons were based on ANOVA and 
Tukey's posthoc test, using Prism 3.0 software. * Significantly 
different from healthy controls (SIV- group) (p < 0.05); † Sig-
nificantly different from SIVΔnef macaques (p < 0.05); †† Sig-
nificantly different from SIV+ SP (p < 0.05).Retrovirology 2009, 6:29 http://www.retrovirology.com/content/6/1/29
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bone marrow lymphopoiesis results in the specific and
reciprocal expansion of the granulocytic compartment in
bone marrow [39].
Our results showed that, at 8 months post-inoculation
(p.i.), the extent of PMN apoptosis is higher than that
observed at 2 months p.i., while the levels of viral replica-
tion remain quite similar [30]. In addition, during the
acute phase, the levels of 107 copies/ml in RMs infected
with the pathogenic strain is associated with PMN death;
interestingly in RMs infected with the live attenuated Δnef
strain, despite a viral load of 105 copies/ml at the peak
(day 14 p.i.), no PMN death was observed [30]. This level
of viral replication corresponds to that observed during
the chronic phase. Altogether, these data suggest that,
while a certain threshold of viral particles is required for a
direct effect on cell death, extracellular factors could par-
ticipate in PMN dysregulation. Because it has been shown
that inflammatory cytokines inhibit PMN apoptosis
[40,41], we then determined in the plasma the amount of
IL-8, TNF-α, and IL-1β. Blood was collected in sterile
EDTA-treated vacuum tubes and immediately centrifuged
at 400 g for 15 minutes at 4°C. IL-8, TNF-α, and IL-1β
were detected simultaneously by using the human inflam-
matory cytokine cytometric bead array (CBA) kit (BD
Pharmingen), which has been validated for cytokine
measurements in RMs after Toll-like receptor (TLR) stim-
ulation (data not shown).
Firstly, we found that IL-8 and IL-1β plasma levels were
significantly lower in SIV+ moderate progressors as com-
pared to SIV+ slow progressors and SIVΔnef  macaques
(Figure 3A). Secondly, pre-incubation of whole blood
samples from moderate progressors with IL-8 (100 ng/ml)
or IL-1β (100 ng/ml) for 4 hours significantly reduced
PMN apoptosis as compared to samples incubated with
PBS [percentage of annexin V+ cells: 8.2 ± 1.3, 9.5 ± 2.1
and 18.5 ± 4.3 for the samples incubated with IL-8, IL-1β
(R&D), or PBS, respectively] (Figure 3B). In contrast, TNF-
α was undetectable in the plasma of SIV-infected
PMN functions during chronic infection of rhesus macaques  with the pathogenic SIVmac251 strain or the attenuated  SIVΔnef strain Figure 2
PMN functions during chronic infection of rhesus 
macaques with the pathogenic SIVmac251 strain or 
the attenuated SIVΔnef strain. Basal CD11b expression 
on the PMN surface (A) and basal ROS production (B) were 
studied in whole blood samples. Results are expressed as 
Mean Fluorescence Intensity (MFI). Data are reported as 
means ± SEM. Comparisons were based on ANOVA and 
Tukey's posthoc test, using Prism 3.0 software. * Significantly 
different from healthy controls (SIV- group) (p < 0.05); † Sig-
nificantly different from SIVΔnef macaques (p < 0.05); †† Sig-
nificantly different from SIV+ SP (p < 0.05).
Levels of pro-inflammatory cytokines during chronic infec- tion of rhesus macaques with the pathogenic SIVmac251  strain Figure 3
Levels of pro-inflammatory cytokines during chronic 
infection of rhesus macaques with the pathogenic 
SIVmac251 strain. A) IL-8 and IL-1β levels during chronic 
infection of rhesus macaques with the pathogenic SIVmac251 
strain (slow progressors SIV+ SP, and moderate progressors, 
SIV+ MP) or the attenuated SIVΔnef strain. Plasma levels of IL-
8 and IL-1β were measured by using the inflammatory 
cytokine cytometric bead array (CBA).* Significantly different 
(p < 0.05). B) Effect of IL-8 and IL-1β on PMN survival. 
Whole blood samples from SIV+ rhesus macaques were incu-
bated at 37°C for 4 hours either with IL-8 (100 ng/ml), IL-1 
(100 ng/ml) or PBS. Results are expressed as percentage of 
annexin V+/7-AAD- cells (early apoptotic cells). Data are 
reported as means ± SEM. Comparisons were based on 
ANOVA and Tukey's posthoc test, using Prism 3.0 software. 
* Significantly different from samples incubated with PBS 
alone (p < 0.05).Retrovirology 2009, 6:29 http://www.retrovirology.com/content/6/1/29
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macaques. The absence of detection of TNF-α in chroni-
cally SIV-infected rhesus macaques is consistent with a
recent report [42]. Indeed, the authors did not observe
increased levels of pro-inflammatory cytokines despite
increased levels of plasma LPS. Thus, the absence of
inflammatory cytokines might lead to an abnormal ten-
dency of PMN to die.
Finally, one consequence of such abnormal PMN apopto-
sis could be to facilitate the dissemination of SIV/HIV in
vivo by modulating immune responses. Apoptotic cells are
sources of biologically active oxidized phospholipids
which serve as recognition signals on apoptotic cells, facil-
itating phagocytosis by macrophages [43]. Engulfment of
apoptotic PMN has been shown to inhibit the production
of pro-inflammatory mediators by macrophages, through
the secretion of anti-inflammatory cytokines such as TGF-
β [44]. In this context, we recently demonstrated that TGF-
β is increased in the tissues of SIV-infected RMs [25]. Such
anti-inflammatory events can inhibit antigen presentation
and promote microbial growth within macrophages [45],
HIV replication [46], as well as the expansion of IL-17-
producing cells [47].
In conclusion, our data demonstrate for the first time, to
our knowledge, in SIV-infected macaques abnormal PMN
deaths that increased in monkeys progressing faster to
AIDS. This abnormality might therefore participate in the
general immune defect leading to clinical outcomes in SIV
infection.
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